Winter, J.; Kunze, R.; Veit, N.; Kuerpig, S.; Meisenheimer, M.; Kraus, D.; Glassmann, A.; Probstmeier, R.
Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options. Cancers 2023, 15, 1415.
https://doi.org/10.3390/cancers15051415
AMA Style
Winter J, Kunze R, Veit N, Kuerpig S, Meisenheimer M, Kraus D, Glassmann A, Probstmeier R.
Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options. Cancers. 2023; 15(5):1415.
https://doi.org/10.3390/cancers15051415
Chicago/Turabian Style
Winter, Jochen, Rudolf Kunze, Nadine Veit, Stefan Kuerpig, Michael Meisenheimer, Dominik Kraus, Alexander Glassmann, and Rainer Probstmeier.
2023. "Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options" Cancers 15, no. 5: 1415.
https://doi.org/10.3390/cancers15051415
APA Style
Winter, J., Kunze, R., Veit, N., Kuerpig, S., Meisenheimer, M., Kraus, D., Glassmann, A., & Probstmeier, R.
(2023). Targeting of Glucose Transport and the NAD Pathway in Neuroendocrine Tumor (NET) Cells Reveals New Treatment Options. Cancers, 15(5), 1415.
https://doi.org/10.3390/cancers15051415
